ALLMedicine™ Cytomegalovirus Center
Research & Reviews 7,671 results
https://doi.org/10.1038/s41590-023-01463-8
Nature Immunology; Cheng MI, Li JH et. al.
Mar 18th, 2023 - Viral infection outcomes are sex biased, with males generally more susceptible than females. Paradoxically, the numbers of antiviral natural killer (NK) cells are increased in males. We demonstrate that while numbers of NK cells are increased in m...
https://doi.org/10.1186/s12969-023-00807-w
Pediatric Rheumatology Online Journal; Zhang T, Yu Z et. al.
Mar 18th, 2023 - Cytomegalovirus (CMV) plays an important role in the pathogenesis of systemic lupus erythematosus (SLE). However, it is not clear whether the anti-CMV treatment has an impact on the prognosis of SLE patients with CMV infection. We aimed to analyze...
https://doi.org/10.1016/j.nut.2023.111999
Nutrition (Burbank, Los Angeles County, Calif.); Hayashi A, Taki Y et. al.
Mar 17th, 2023 - A 76-y-old Japanese man who had undergone gastrectomy 4.5 y earlier experienced 2 wk of sore throat, heartburn, and difficulty swallowing. Endoscopy showed deep, craterlike, longitudinal ulcers in the lower and middle esophagus. Immunohistochemist...
https://doi.org/10.1111/crj.13600
The Clinical Respiratory Journal; Nenna R, Zhai J et. al.
Mar 17th, 2023 - Cytomegalovirus (CMV) seropositivity has been recently linked to severity and progression of asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). To date, no longitudinal study has addressed the relation of CMV serology to le...
https://doi.org/10.1007/s10792-023-02656-8
International Ophthalmology; Loubsens E, Adam R et. al.
Mar 16th, 2023 - To review management, treatment, and outcomes of patients with necrotizing herpetic retinitis (NHR) to propose an algorithm for first-line management of NHR. Retrospective evaluation of a series of patients with NHR at our tertiary center between ...
Guidelines 10 results
https://doi.org/10.1111/bjh.17754
British Journal of Haematology; Morton S, Dignan F et. al.
Aug 18th, 2021 - Cytomegalovirus serological testing in potential allogeneic haematopoietic stem cell transplant recipients: A British Society for Haematology Good Practice Paper.|2021|Morton S,Dignan F,Osman H,Potter M,Pagliuca T,|blood,immunology,diagnosis,preve...
https://doi.org/10.1016/j.ajog.2021.06.079
American Journal of Obstetrics and Gynecology; , Prabhu M et. al.
Jun 26th, 2021 - Soft markers were originally introduced to prenatal ultrasonography to improve the detection of trisomy 21 over that achievable with age-based and serum screening strategies. As prenatal genetic screening strategies have greatly evolved in the las...
https://doi.org/10.1016/j.jogc.2021.05.015
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Boucoiran I, Yudin M et. al.
Jun 6th, 2021 - To provide an update on current recommendations for cytomegalovirus (CMV) infection during pregnancy. The objectives of this guideline are: TARGET POPULATION: Patients of child-bearing age, pregnant patients, and patients planning a pregnancy. The...
https://doi.org/10.1097/TP.0000000000002191
Transplantation Kotton CN, Kumar D et. al.
Mar 30th, 2018 - Despite recent advances, cytomegalovirus (CMV) infections remain one of the most common complications affecting solid organ transplant recipients, conveying higher risks of complications, graft loss, morbidity, and mortality. Research in the field...
https://doi.org/10.1016/j.jogc.2017.11.018
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Yinon Y, Farine D et. al.
Feb 16th, 2018 - To review the principles of prenatal diagnosis of congenital cytomegalovirus (CMV) infection and to describe the outcomes of the affected pregnancies. Effective management of fetal infection following primary and secondary maternal CMV infection d...
Drugs 96 results see all →
Clinicaltrials.gov 518 results
https://clinicaltrials.gov/ct2/show/NCT02257892
Mar 10th, 2023 - This study is designed to evaluate patients with suspected or identified novel immune disorders, with a focus on abnormal immune homeostasis potentially due to defects in activation or apoptosis. Blood relatives of enrolled patients will also be e...
https://clinicaltrials.gov/ct2/show/NCT03910478
Mar 10th, 2023 - This is a randomized clinical trial to assess whether a subject centered, self-collection of Dried blood spots (DBS) samples will improve compliance with the clinical recommendation of weekly Cytomegalovirus (CMV) testing of Hematopoietic cell tra...
https://clinicaltrials.gov/ct2/show/NCT05763823
Mar 10th, 2023 - The purpose of this study is to evaluate the efficacy and safety of once-a-day orally or IV dose of Letermovir (MK-8228) in Chinese adult Hematopoietic Stem Cell Transplant (HSCT) recipients for the prevention of clinically significant Cytomegalov...
https://clinicaltrials.gov/ct2/show/NCT03728426
Mar 8th, 2023 - This is a Phase II clinical trial. Phase II clinical trials test the safety and effectiveness of an investigational drug to learn whether the drug works in treating a specific disease. "Investigational" means that the drug is being studied. The FD...
https://clinicaltrials.gov/ct2/show/NCT01207141
Mar 7th, 2023 - This open-label clinical trial will evaluate the pharmacodynamics, pharmacogenomics and early efficacy and safety of steroid-free Tacrolimus (TAC) monotherapy and its minimization after induction with rabbit, anti-human thymocyte globulin (rATG, G...
News 511 results
https://www.mdedge.com/familymedicine/article/260933/dermatology/palmar-rash
MDedge Family Medicine;
Jan 31st, 2023 - This patient’s targetoid and tingling skin lesions, in association with herpes simplex virus (HSV) infection, are a classic presentation of erythema multiforme (EM). EM is an acute, self-limited, immune-mediated process that most commonly arises i.
https://www.medpagetoday.com/hematologyoncology/hematology/102638
Jan 13th, 2023 - An investigational, off-the-shelf T-cell therapy appears to be effective against six different viral infections that are common in patients who undergo allogeneic hematopoietic cell transplantation (HCT), according to results from a phase II trial...
https://www.medpagetoday.com/genetics/generalgenetics/102358
Dec 21st, 2022 - A gene therapy for a rare type of severe combined immunodeficiency (SCID) was safe and sufficiently restored T-cell immunity in an early trial, results from a phase I/II study showed. At a single center, all 10 infants with Artemis-deficient SCID ...
https://www.medpagetoday.com/infectiousdisease/generalinfectiousdisease/102181
Dec 9th, 2022 - Public health officials released details on how a 7-year-old boy from Texas died from a rare rabies infection last year. Although the boy had informed his parents he had been bitten by a bat while playing outside his apartment home, there were no ...
https://www.medscape.com/viewarticle/984827
Dec 1st, 2022 - NEW YORK (Reuters) - Moderna Inc's top scientist said on Tuesday that the vaccine maker has learned how to better recruit from diverse populations for its clinical trials from running its COVID-19 vaccine studies. Moderna Chief Medical Officer Pau...